TSR Desk · science · 14 September 2026, 07:00 UTC
HypoKG: Evidence-Disciplined Biomedical Hypothesis Generation Beyond Endpoint Knowledge
- What
- HypoKG: Evidence-Disciplined Biomedical Hypothesis Generation Beyond Endpoint Knowledge
- Who
- arxiv.org
- When
- 14 September 2026, 04:00 UTC
- Category
- Science
- Primary source
- https://arxiv.org/abs/2609.12260
- What is not known
- This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.
To study this, we combine three major biological databases: the Kyoto Encyclopedia of Genes and Genomes (KEGG), Rhea, and UniProt, into a unified biochemical knowledge graph and construct a benchmark of 550 paths connecting enzyme sources to rare disease endpoints, yielding 13,200 hypotheses from six LLMs under four conditions varying the biological information each model receives: source enzyme only, full biological path, or source and disease endpoint only. It comes from a paper posted to arXiv on 14 September 2026. Large language models (LLMs) can generate biomedical hypotheses, but it remains unclear whether they truly reason from scientific evidence or simply produce convincing-sounding ideas. Hypotheses are scored using an expert-derived five-criterion rubric on a 1-5 scale per criterion. We find that models given both the source and disease endpoint often produce the highest-scoring hypotheses, showing that LLMs can generate compelling ideas from minimal information. However, these hypotheses are less grounded in the evidence. In contrast, models given the full biological path generate hypotheses more consistent with known mechanistic relationships. We call this evidence-disciplined reasoning. To confirm this effect, we shuffled intermediate path steps while keeping endpoints fixed. Evidence grounding dropped significantly (delta = -0.793, p < 0.001), confirming models genuinely used path structure during reasoning. Our findings show that knowledge graphs support hypothesis generation in two ways: they identify biological endpoint pairs absent from the literature, and their mechanistic paths guide how LLMs reason between them.
Why it counts
To study this, we combine three major biological databases: the Kyoto Encyclopedia of Genes and Genomes (KEGG), Rhea, and UniProt, into a unified biochemical knowledge graph and construct a benchmark of 550 paths connecting enzyme sources to rare disease endpoints, yielding 13,200 hypotheses from six LLMs under four conditions varying the biological information each model receives: source enzyme only, full biological path, or source and disease endpoint only.
Sources
Primary source: primary source
What is not known
This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.
No clip. The article still stands.